DexCom
DXCM
954 hedge funds and large institutions have $47.4B invested in DexCom in 2023 Q2 according to their latest regulatory filings, with 125 funds opening new positions, 370 increasing their positions, 312 reducing their positions, and 71 closing their positions.
76% more first-time investments, than exits
New positions opened: 125 | Existing positions closed: 71
19% more repeat investments, than reductions
Existing positions increased: 370 | Existing positions reduced: 312
10% more capital invested
Capital invested by funds: $42.9B → $47.4B (+$4.45B)
5% more funds holding
Funds holding: 905 → 954 (+49)
0.37% less ownership
Funds ownership: 95.57% → 95.2% (-0.37%)
22% less funds holding in top 10
Funds holding in top 10: 18 → 14 (-4)
33% less call options, than puts
Call options by funds: $424M | Put options by funds: $629M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$231M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$104M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$92.9M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$82.1M |
| 5 |
Janus Henderson Group
London,
|
+$73.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$457M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$186M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$159M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$108M |
| 5 |
Millennium Management
New York
|
-$93.3M |
DXCM Hedge Fund Activity: Q2 2023 in Review
954 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2023, worth a combined $47.4B — up 10% from $42.9B a quarter earlier.
Buyers outnumbered sellers: 125 funds opened new DXCM positions and 71 closed out — a net gain of 54 holders — while 370 added to existing stakes and 312 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $231M. The largest seller was Citadel Advisors, cutting an estimated $457M.
- 954 institutional investors held DexCom (DXCM) as of Q2 2023, up from 905 in Q1 2023.
- Funds reported $47.4B of DexCom stock for Q2 2023, up 10% quarter-over-quarter.
- 125 funds opened new DexCom positions in Q2 2023 and 71 closed out, a net change of +54 holders.
- The largest DexCom buyer in Q2 2023 was JP Morgan Chase, an estimated $231M added.
- The largest DexCom seller in Q2 2023 was Citadel Advisors, an estimated $457M sold.
Based on aggregated 13F filings for Q2 2023.